Navigation Links
NIH announces phase III clinical trial of creatine for Parkinson's disease

The NIH National Institute of Neurological Disorders and Stroke (NINDS) today is launching a large-scale clinical trial to learn if the nutritional supplement creatine can slow the progression of Parkinson's disease (PD). While creatine is not an approved therapy for PD or any other condition, it is widely thought to improve exercise performance. The potential benefit of creatine for PD was identified by Parkinson’s researchers through a new rapid method for screening potential compounds.

The double-blind, placebo-controlled, phase III study is one of the largest PD clinical trials to date. It will enroll 1720 people with early-stage PD at 51 medical centers in the United States and Canada.

"This study is an important step toward developing a therapy that could change the course of this devastating disease," says Elias A. Zerhouni, M.D., director of the NIH. "The goal is to improve the quality of life for people with Parkinson's for a longer period of time than is possible with existing therapies." Currently there is no treatment that has been shown to slow the progression of PD.

The trial is the first large study in a series of NINDS-sponsored clinical trials called NET-PD (NIH Exploratory Trials in Parkinson's Disease). NINDS has organized this large network of sites to allow researchers to work with PD patients over a long period of time, with a goal of finding effective and lasting treatments. NET-PD builds on a developmental research process—from laboratory research to pilot studies in a select group of patients, to the definitive phase III trial of effectiveness in people with Parkinson’s disease.

"This study is an example of the Institute's commitment to Parkinson's research," says NINDS director Story C. Landis, Ph.D. "We are trying to explore every possible option for reducing the burden of this disease."

Participants will be in the phase III study for five to seven years. The effort will be led by Ka
'"/>

Source:NIH/National Institute of Neurological Disorders and Stroke


Page: 1 2 3

Related biology news :

1. Wiley announces publication of Databasing the Brain
2. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
3. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
4. Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer
5. GlycoFi announces the first production of antibodies with human glycosylation in yeast
6. NHGRI announces new sequencing targets
7. CHAVI announces international search for genes affecting HIV response
8. NHGRI announces latest sequencing targets
9. MUHC announces a transplant first in Quebec
10. St. Jude announces breakthrough in eye cancer treatment
11. Worlds largest rainforest drying experiment completes first phase
Post Your Comments:
(Date:9/22/2014)... could be much more useful in homes, if they ... see the world with cameras and lasers, which have ... are hidden in clutter. A complementary way robots can ... of small ultra-high frequency radio-frequency identification (UHF RFID) tags. ... an RFID-equipped robot to search a room for the ...
(Date:9/22/2014)... 7,000 geoscientists will gather in Vancouver, British Columbia, Canada, ... America,s 126th Annual Meeting & Exposition on 19-22 October ... transportation of crude oil, earthquake prediction problems, and how ... and Tribulations of Life on an Active Subduction Zone, ... , A broad range of topics will be presented ...
(Date:9/21/2014)... Diego, have developed a program that predicts the placement ... based on sequences of DNA. They describe their analysis ... cells in a paper published in Nature Methods ... have the same blueprint, the same DNA, although they ... the report. "Skin cells protect, nerve cells send signals, ...
Breaking Biology News(10 mins):New RFID technology helps robots find household objects 2New RFID technology helps robots find household objects 3Geoscience topics in the spotlight -- Vancouver, BC 2Geoscience topics in the spotlight -- Vancouver, BC 3Geoscience topics in the spotlight -- Vancouver, BC 4Geoscience topics in the spotlight -- Vancouver, BC 5Program predicts placement of chemical tags that control gene activity 2
... Genomics Consortium’s (IGC) Expression Project for Oncology (expO) ... 60 tumor specimens, completing the initial phase of ... dedicated to standardized gene expression data. The clinically ... through the National Center for Biotechnology Information web ...
... Medical Center implanted Artificial Silicon Retina (ASR) microchips in ... caused by retinitis pigmentosa (RP). The implant is a ... inch thick, less than the thickness of a human ... The fifth patient is scheduled for a later date. ...
... in a taste receptor gene influences taste sensitivity of ... preferences and food selection, report a team of researchers ... genes, age and culture also contribute to taste preferences, ... findings may help to explain why some children are ...
Cached Biology News:Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses 2Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses 3Ophthalmologists implant five patients with artificial silicon retina microchip 2Ophthalmologists implant five patients with artificial silicon retina microchip 3Children's taste sensitivity and food choices influenced by taste gene 2Children's taste sensitivity and food choices influenced by taste gene 3
(Date:9/22/2014)... DUBLIN , September 22, 2014 ... has announced the addition of the "Global ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... are added to a system to detect and ... Reagents are generally used in laboratories to prepare, ...
(Date:9/22/2014)... tumor cells (CTCs) in a mouse model of pancreatic ... groups of CTCs, including significant differences from the primary ... metastases. In their study reported in the Sept. ... the Massachusetts General Hospital (MGH) Cancer Center identified several ... that may prove to be targets for improved treatment ...
(Date:9/22/2014)... highly sensitive chemical sensor based on the crystalline flaws ... that the researchers were able to exploit to increase ... The study is available online in advance of print ... asst professor of mechanical and industrial engineering in the ... post doc where they are doing research in graphene ...
(Date:9/22/2014)... NEW YORK , Sept. 22, 2014 ... US demand for specialty biocides is forecast to ... 2018. In volume terms, demand is projected to increase ... the same period. A strong rebound in construction expenditures ... and paint and coatings markets, while growth in consumer ...
Breaking Biology Technology:Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 3Massachusetts General study reveals gene expression patterns in pancreatic CTCs 2Massachusetts General study reveals gene expression patterns in pancreatic CTCs 3Graphene imperfections key to creating hypersensitive 'electronic nose' 2US Biocides Market 2US Biocides Market 3
... China, Nov. 9, 2010 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...
... With Pfizer -- CHARLOTTESVILLE, Virginia, November 9, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
... Nov. 9, 2010 Verenium Corporation (Nasdaq: ... of high-performance industrial enzyme solutions, today announced that Janet ... the upcoming Jefferies 10th Global Clean Technology Conference.  The ... on Tuesday, November 16, 2010 and will take place ...
Cached Biology Technology:China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 2China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 3China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 4China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 5China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 6China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 7China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 8Biovista Announces a Drug Repositioning Collaboration With Pfizer 2Biovista Announces a Drug Repositioning Collaboration With Pfizer 3Biovista Announces a Drug Repositioning Collaboration With Pfizer 4Biovista Announces a Drug Repositioning Collaboration With Pfizer 5Biovista Announces a Drug Repositioning Collaboration With Pfizer 6Biovista Announces a Drug Repositioning Collaboration With Pfizer 7Biovista Announces a Drug Repositioning Collaboration With Pfizer 8Verenium to Present at Jefferies 10th Global Clean Technology Conference 2Verenium to Present at Jefferies 10th Global Clean Technology Conference 3
... Sciex present the 4000 Q TRAP(TM) ... triple quadrupole/linear ion trap mass spectrometer ... or proteomics researcher. Innovative Linear Ion ... in mass spectrometry brings together fast, ...
... Alsevers solution is an isotonic, balanced salt solution. ... which permits the storage of whole blood at ... an equal volume of blood is collected into ... thoroughly, mixed. The solution is placed in a ...
Rabbit polyclonal antibody to Glutathione-S-Transferase (GST)...
Chicken polyclonal antibody to Glutathione-S-Transfrease (GST)...
Biology Products: